Chf Nyha II-III(Indah)

Embed Size (px)

Citation preview

  • 8/18/2019 Chf Nyha II-III(Indah)

    1/31

    CHF NYHA II-III e.c. CAD 

    BY

    INDAH NURMAWATI

    C 111 03 134

    Case presentation

  • 8/18/2019 Chf Nyha II-III(Indah)

    2/31

    PATIENT IDENTITYName : Mr. A

    Media! Reord : 3"#1##

     A$e : #4 %ears o!d

     Address : Ba&'(a&

  • 8/18/2019 Chf Nyha II-III(Indah)

    3/31

    HISTORY TAKING C)ie* omp!aint : +)ortness o* (reat) Histor% ta,in$ :

    ' -atient *e!t s)ortness o* (reat) sine to ee,s

    a$o (e*ore admitane. D%spnea e/aer(ated (%D%spnea e/aer(ated (%atiit% and not (% eat)er )an$eatiit% and not (% eat)er )an$e. Histor% o*s)ortness o* (reat) sine *o&r %ears a$o&nontin&o&s!%. He s!ept it) &se one pi!!o. -atiento*ten a,e &p in t)e ni$)t (ea&se d%spnea.

    '+ometimes t)ere2s )est pain )en d%spnea. C)estpain as *e!t in t)e !e*t )est not penetrate to (a,and pain o&!d (e !oa!ied.

  • 8/18/2019 Chf Nyha II-III(Indah)

    4/31

    HISTORY TAKING…' +e!!in$ in t)e (ot) o* !e$ sine to ee,s

    a$o.'

    T)ere as no *eer )eada)e.' T)ere2s no o&$) na&sea and omit. He&s&a!!% *e!t pain at t)e &pper stoma).

    ' Histor% o* inreasin$ mit&ration in t)e ni$)t

    sine to %ears a$o more o*ten t)irst% and)&n$r%.

    ' Urinate and de*eate as norma!.

  • 8/18/2019 Chf Nyha II-III(Indah)

    5/31

    PAST MEDICAL HISTORYT)e patient )ae $one to t)e dotor it)

    t)e same omp!aint on 00# and )ae

    )ad t)erap% (&t not re$&!ar!%.T)e patient denied )ae )%pertension

    dia(etes me!!it&s.

  • 8/18/2019 Chf Nyha II-III(Indah)

    6/31

    RISK FACTORHe )ae smo,ed sine )e as %o&n$

    15 pa,5da%.

    He as not a!o)o!i.Man #4 %ears o!d

  • 8/18/2019 Chf Nyha II-III(Indah)

    7/31

    PHYSICAL EXAMINATION 6ita! +i$n :

    7 B!ood press&re : 130580 mmH$7 -&!se : 94 /5min7 Inspirator% rate : 9 /5min

    7 Bod% temperat&re : 3#oC Head ;/amination :

    7 ;%es : t)ere as no anemis no %anosis no iter&s7 Ne, :

  • 8/18/2019 Chf Nyha II-III(Indah)

    8/31

    PHYSICAL EXAMINATIONHeart Examination :

    7 Inspetion : it&s ordis as no isi(!e

    7-a!pation : it&s ordis as no pa!pa(!e

    7 -er&ssion : idenin$ o* )eart sie7  A&s&!tation : re$&!ar o* I5II Heart +o&nd no m&rm&r Stomach Examination :• Inspection : normal

    • Palpation : no mass, tenderness on regioepigastrium• Percussion : tympani, mild acites (+)• Auscultation : peristaltic sound (+), normal

    Extremity : there as oedema preti!ial and dorsum pedis

  • 8/18/2019 Chf Nyha II-III(Indah)

    9/31

    ADDITIONAL EXAMINATIONComp!ete (!oodComp!ete (!ood

    WBC : 83 / 103 5mm3

    H>B : 1 $5d!

    RBC : 444 / 10 5mm3

    -?T : 0 / 103 5mm3

    HCT : 394 @

    B!ood e!etro!%te

     +odi&m+odi&m : 1# mmo!5!

     -otassi&m-otassi&m : " mmo!5!

     C)!orideC)!oride : 83 mmo!5!

    Heart enim

    C : #8

    CMB : 33 U5!

    Troponin'T : 01 n$5m!

    B!ood )emistr%B!ood )emistr%Random (!ood s&$ar Random (!ood s&$ar : 4 m$5d!astin$ (!ood s&$ar : 131 m$5d!

    +>T : 98 &5!

    +>-T : 1" &5!

    C)o!estero! tota! : 01 m$5d!C)o!estero! HD? : 10 m$5d!

    C)o!estero! ?D? : "1 m$5d!

    Tri$!%seride : 03 m$5d!

    -rotein tota! : #

     A!(&min : #

    >!o(&!in : 9Ure&m : 34

    Creatinin : 0

    Uri aid : 9.0

  • 8/18/2019 Chf Nyha II-III(Indah)

    10/31

    ;C> :;C> : '+in&s r)%tme'+in&s r)%tme

    '?atera! a!! is)emia'?atera! a!! is)emia

    '?AD'?AD

  • 8/18/2019 Chf Nyha II-III(Indah)

    11/31

    ADDITIONAL EXAMINATION C)est /'ra% :

    Cardiome$a!% it)

    si$n o* p&!mona!edema

  • 8/18/2019 Chf Nyha II-III(Indah)

    12/31

    ADDITIONAL EXAMINATION

    ;)oardio$rap)% :' CH'CAD

    ' -H

  • 8/18/2019 Chf Nyha II-III(Indah)

    13/31

    SUGGESTION ADDITIONAL

    EXAMINATIONCoronar% an$io$rap)%

  • 8/18/2019 Chf Nyha II-III(Indah)

    14/31

    DIAGNOSISCH NYHA III'I6 e. CAD

    DM t%pe

  • 8/18/2019 Chf Nyha II-III(Indah)

    15/31

    MANAGEMENT /%$en : 3'4 ?5m I6D NaC! 08 @I6D NaC! 08 @ ?oop di&retis : &rosemide amp51 )o&rs5I6?oop di&retis : &rosemide amp51 )o&rs5I6

     to red&e preload   Aspi!ets 90 m$ 0'1'0

      to preent a$$re$ate p!ate!et -!ai/ "# m$ 0'1'0

      to preent prod&tion o* trom(o/ane A sop!ate!et not a$$re$ate

     AC;I : Captopri! 1# m$ /1 AC;I : Captopri! 1# m$ /1 arteridi!ator and enodi!ator to red&e a*ter!oad

    == sparin$ di&retis : +pirono!a,tone # m$ 1'0'0sparin$ di&retis : +pirono!a,tone # m$ 1'0'0

    spesi*is anta$onist o* a!dosteronespesi*is anta$onist o* a!dosterone

  • 8/18/2019 Chf Nyha II-III(Indah)

    16/31

    MANAGEMENT... Nitrat : arsor(id 10 m$ 3/1Nitrat : arsor(id 10 m$ 3/1

      6enodi!ator 6enodi!ator  : to red&e: to red&e filling pressurefilling pressure

    +imastatin 10 m$ 0'0'1

     Atrapid ''

  • 8/18/2019 Chf Nyha II-III(Indah)

    17/31

    DISCUSSION

  • 8/18/2019 Chf Nyha II-III(Indah)

    18/31

      ORONARY ARTERY DISEASE 

    Coronar% arter% disease ECADF o&rs

    )en t)e arteries t)at s&pp!% (!ood to

    t)e )eart m&s!e Et)e oronar% arteriesF(eome )ardened and narroed.T)e

    arteries )arden and narro d&e to

    (&i!d&p o* a materia! a!!ed p!aG&e Ep!a,F

    on t)eir inner a!!s. T)e (&i!d &p o*

    p!aG&e is ,non as at)eros!erosis

  • 8/18/2019 Chf Nyha II-III(Indah)

    19/31

    -at)o$enesis: M%oardia! s&pp!%

    Narro esse! (ea&se*!aG&e

    ormin$ o* trom(&s (ea&se

    trom(osite a$re$ation

    +pasme oronaria arter%

    M%oardia! reG&irements

     Atiit% inrease

  • 8/18/2019 Chf Nyha II-III(Indah)

    20/31

    RISK FACTORSRISK FACTORS

    Risk Factors That Cannot Be Modified:Risk Factors That Cannot Be Modified:

    7 Age.Age. As %o& $et o!der %o&r ris, *or CAD inreases. As %o& $et o!der %o&r ris, *or CAD inreases.Men ris, inreases a*ter a$e 4#.Men ris, inreases a*ter a$e 4#.

    Women ris, inreases a*ter a$e ##.Women ris, inreases a*ter a$e ##.

    7 Family history of early heart disease.Family history of early heart disease. Heart disease dia$nosed (e*ore a$e ## in *at)er orHeart disease dia$nosed (e*ore a$e ## in *at)er or

    (rot)er.(rot)er.

    Heart disease dia$nosed (e*ore a$e # in mot)er orHeart disease dia$nosed (e*ore a$e # in mot)er or

    sister.sister. 

  • 8/18/2019 Chf Nyha II-III(Indah)

    21/31

    RISK FACTORS…RISK FACTORS…

    Risk Factors That Can Be Modified:Risk Factors That Can Be Modified:

    Hi$) (!ood )o!estero!Hi$) (!ood )o!estero!

    Hi$) (!ood press&reHi$) (!ood press&reCi$arette smo,in$Ci$arette smo,in$

    Dia(etesDia(etes

    erei$)t or o(esit%erei$)t or o(esit%

    ?a, o* p)%sia! atiit%?a, o* p)%sia! atiit%

  • 8/18/2019 Chf Nyha II-III(Indah)

    22/31

    C?INIC +YNDRM CAD :

     An$ina -etoris

    In*ar, Mio,ard7 Non' ae7 ae

  • 8/18/2019 Chf Nyha II-III(Indah)

    23/31

    CONGESTIVE HEART FAILURE

    (CHF)

    Con$estie )eart *ai!&re ECHF is anCon$estie )eart *ai!&re ECHF is an

    im(a!ane in p&mp *&ntion in )i) t)eim(a!ane in p&mp *&ntion in )i) t)e

    )eart *ai!s to maintain t)e ir&!ation o*)eart *ai!s to maintain t)e ir&!ation o*(!ood adeG&ate!%.(!ood adeG&ate!%.

  • 8/18/2019 Chf Nyha II-III(Indah)

    24/31

    W)en ardia o&tp&t (eame

    inadeG&ate to *&!! *i!! t)e reG&irement o*

    meta(o!ism )eart o&!d ma,eme)anism o* ompensation. B&t )en

    t)e me)anism )ae (een &se

    ma/ima!!% and ardia o&tp&t sti!!inadeG&ate t)en s%mptoms o* )eart

    *ai!&re o&!d (e arise.

  • 8/18/2019 Chf Nyha II-III(Indah)

    25/31

    NYHA la!"!ca#!$% $" Hea

    YHA la!"!ca#!$% $" Hea

    Fa!l'&e

    a!l'&e 

    II No s%mptoms and no !imitation in ordinar%No s%mptoms and no !imitation in ordinar%p)%sia! atiit%.p)%sia! atiit%.

    IIII Mi!d s%mptoms and s!i$)t !imitation d&rin$Mi!d s%mptoms and s!i$)t !imitation d&rin$ordinar% atiit%. Com*orta(!e at rest.ordinar% atiit%. Com*orta(!e at rest.

    IIIIII Mar,ed !imitation in atiit% d&e toMar,ed !imitation in atiit% d&e tos%mptoms een d&rin$ !ess't)an'ordinar%s%mptoms een d&rin$ !ess't)an'ordinar%atiit%. Com*orta(!e on!% at rest.atiit%. Com*orta(!e on!% at rest.

    I6I6 +eere !imitations. ;/perienes s%mptoms+eere !imitations. ;/perienes s%mptomseen )i!e at rest.een )i!e at rest.

  • 8/18/2019 Chf Nyha II-III(Indah)

    26/31

    T(e F&a)!%*(a) c&!#e&!a "$& HF

    (e F&a)!%*(a) c&!#e&!a "$& HF

    CHF considered present if two major or one major pls two minor criteriaCHF considered present if two major or one major pls two minor criteria

    are flfilledare flfilled 

    Major CriteriaMajor Criteria

     !aro"ysmal noctrnal dyspnoea!aro"ysmal noctrnal dyspnoea  #eck $ein distension#eck $ein distension

     RalesRales

     Radiographic cardiomegalyRadiographic cardiomegaly  Acte plmonary oedemaActe plmonary oedema  %& gallop%& gallop  Hepatojglar refl"Hepatojglar refl"  Circlation time ' () secondsCirclation time ' () seconds

     *eight loss*eight loss +.) kg in ) days in response to treatment of CHF+.) kg in ) days in response to treatment of CHF  !lm.oedema, $isc. congestion or cardiomegaly at atopsy!lm.oedema, $isc. congestion or cardiomegaly at atopsy

  • 8/18/2019 Chf Nyha II-III(Indah)

    27/31

    T(e F&a)!%*(a) c&!#e&!a "$& HF

    (e F&a)!%*(a) c&!#e&!a "$& HF

    Minor riteria Bi!atera! an,!e oedema

    Not&rna! o&$) D%spnoea on e/ertion

    Hepatome$a!%

    -!e&ra! e**&sion

    Heart rate ≥ 10 (pm

  • 8/18/2019 Chf Nyha II-III(Indah)

    28/31

    Ma%!"e#a#!$% $" LHFMa%!"e#a#!$% $" LHF

    BrainBrain

    restlessness,restlessness,

    anxiety, generalizedanxiety, generalizedfatigue.fatigue. Kidney Kidney 

    low urine output withlow urine output withsubsequent fluidsubsequent fluidretention, highretention, highafterload due to RAAafterload due to RAA

    cascade activation,cascade activation,kidney failure.kidney failure.

    yspneuyspneu coughcough

    !orward effects!orward effects Backward effectsBackward effects

  • 8/18/2019 Chf Nyha II-III(Indah)

    29/31

    Ma%!"e#a#!$% $" RHFMa%!"e#a#!$% $" RHF

    "eripheral subcutaneous tissue"eripheral subcutaneous tissue

    #iver #iver 

    "ortal syste$"ortal syste$

    %pleen%pleen

    !orward effects!orward effects Backward effectsBackward effects

    "eripheral tissue hypoxia"eripheral tissue hypoxia

    ue to low cardiac outputue to low cardiac outputcaused by failure to delivercaused by failure to deliver

    enough blood to left atriu$enough blood to left atriu$

  • 8/18/2019 Chf Nyha II-III(Indah)

    30/31

    TREATMENTS…

    MANA>IN> CNTRACTI?ITY

    MANA>IN> -R;?AD MANA>IN> AT;R?AD

    N;URHRMNA?

    MDU?ATIN

  • 8/18/2019 Chf Nyha II-III(Indah)

    31/31